January 29, 2024
Federal prosecutors in Pennsylvania dropped insider trading charges against a former executive of the since-merged pharmaceutical company Mylan just weeks before trial due to what defense attorneys said was flimsy evidence against their client.
August 29, 2023
A former Mylan executive told a Pennsylvania federal judge that he could still be defended on charges of insider trading by an attorney who also represented other Mylan higher-ups in a pair of civil lawsuits, waiving any potential conflict of interest in court Tuesday.
November 10, 2022
A former executive at Mylan and its successor Viatris Inc. has been hit with criminal charges and civil claims that he helped a former colleague make millions from stock trades based on insider information in exchange for payoffs in foreign currency, according to an indictment and complaint made public Thursday.